We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.14 | 2.10 | 2.18 | 2.20 | 2.19 | 2.19 | 604,698 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/2/2018 07:37 | Only my second post to board.Flávio I Echo your sentiments. I have a large holding relative to my portfolio. Only aim stock I hold. I accept the risk in investing in this stock and I hold to many to justify adding further equally I am to scared to miss out on the potential to sell any pre phase 3 results. After 12 years in the stock one more month should pass quite quickly. My thoughts were a successful outcome for lupuzor would be the point at which I cash in. Not sure now though. I hope for a lupuzor licensing deal and the opportunity for the company to bring the pipeline forward. It potentially has more to offer than lupuzor alone. May take another 10 years but I think this is what Dr Zimmer will want. And he has a big say in what the company does. | teapottoby | |
21/2/2018 07:36 | Starts Feb, ends Oct, enrols 100 patients minimum but all Phase 3 patients are eligible. Not all start dosing at the same time. | stealth wealth | |
21/2/2018 07:35 | Hamhamham1 Please can i have your comments on this???? "You have not commented about the risk profile I posted about being comfortable about the risk compared to one's wealth rather than a percentage of one's portfolio". This is important and I would like your views???? Its the professional way in investing... | flavio_monteiro | |
21/2/2018 07:32 | Didn’t the clinical trials website say the extension study had not started yet? Said it was this month? So did the people who completed dosing on ph3 say 6 months sgo had no lupuzor since. Also the number of patients on the extension still estimates 100 - i cant find that clinical trials link. | growthinvestor2001 | |
21/2/2018 07:27 | Phase 3 patients and clinicians asked for dosing to continue after the end of the trial, presumably because they experienced or witnessed benefit and an absence of side effects. | stealth wealth | |
21/2/2018 07:15 | The probability is that Phase 3 results will be better than the already excellent Phase 2b, as patients will have been dosed for longer so allowing the drug longer to act. | stealth wealth | |
21/2/2018 07:14 | Hamhamham1 YOUR QUOTE "Yet then yourself and others encourage investors here to keep buying, they're cheap, chance in a lifetime, not gonna fail, etc" Justify this comment please? Can you find ONE ramp or share price prediction that I have posted? I have often quoted PE values to earning - No one on this board seems to understand them! Its nothing impressive the circles I move in. We all have friend that have done well. You have not commented about the risk profile I posted about being comfortable about the risk compared to one's wealth rather than a percentage of one portfolio. This is important and I would like your views???? I DO agree with YOU on overextending oneself in one share.... | flavio_monteiro | |
21/2/2018 07:02 | Fwiw rossy - I don't think ham is working for anyone, he's just a bit of a plonker. I have him on ignore, along with many other bulls/bears who repeat the same things. I think I'm ignoring about a dozen - far more than I have done before. Not sure if covert things are going on, but it is certainly a strange board. GLA | wigwammer | |
20/2/2018 23:18 | Any chance of a "sensible"day to-morrow? Instead of churning out the same old recycled posts again and again why don't we restrict things to any new research or FRESH schools of thought? What on earth would an alien think if they were to stumble upon this forum and read the posts from the last few days? Methinks that we all need to get our act together and act like responsible investors! Just go away and find something useful to do for however long.it may.be before we get the trial results as absolutely nothing anyone says on here,no matter how many times they repeat it,will change a thing! SLEEP ON THIS THOUGHT.! | teddy boy1 | |
20/2/2018 22:01 | I don't know how cheap derampers want to buy.Just jump in!Cause is a chance in life!Big possibilities to be good so yr money will be multiplied by x5,6,7 or 10 times!Clearly it will go over placing price after 28!The market sentiment will drive it.None of us experts in pharma.we all want money! | costax1654x | |
20/2/2018 21:45 | BSF, you seem to be quite confrontational for someone who purports to be a ‘Marketing manager’ for a very successful consultancy firm, you give the impression that you would frighten away any prospective clients, especially after you spent your time regaling them on all the negatives of your very successful firm just so they didn’t make the wrong decision. You also seem to try and mould what has been said to suit your agenda, which seems to be on the negative side of the fence, from what I have read on this board there are a few ‘holders’ | harbourside | |
20/2/2018 21:03 | growthinvestor & ytsa2 - you are both clearly mental...only kidding... I agree completely with your l-o-g-i-c... Obviously some here are from the Jordan Belfort school of selling... | thebigshortfella | |
20/2/2018 20:56 | I spoke to James Pope on 24th Jan. on the day of the placing to try and find out more about reasons etc.SP on that day was i think slightly higher than 144p. On that day he said they were hoping to have an investors evening with Imm. So that was before it fell to recent lows. Thus not convinced related to recent negative sentiment | ytsa2 | |
20/2/2018 20:54 | the presentation evening is there to placate and reassure the peeps that invested at 144p a share who are now thinking they could have got in lower or that they think something may be wrong. The irony is that it was the placing that has caused the share drop and really there is no news to justify the drop. I think it will be neutral and a non event just reiterating the sales pitch they were given before the placing ‘request’ | growthinvestor2001 | |
20/2/2018 20:48 | metis20 - yeah right...sorry to not join in with the illogical rampers... | thebigshortfella | |
20/2/2018 20:45 | Harbourside - Keep up the good,logical work -tbsf's thinking is muddled at best. | metis20 | |
20/2/2018 20:41 | LOL I am the Marketing Manager for a very successful consultancy and therefore have a clear understanding of what "value" is. Not sure that you do though. Please think about what you are writing. If IMM had positive material news they would have to announce it now..not set up a meeting in 7 days time... Has the share price collapsed? No...So why do you think IMM need to put their side of the story? What you are saying doesn't make any sense...All in my opinion of course.... | thebigshortfella | |
20/2/2018 20:31 | BSF, I am not suggesting anything just giving a view. I find it bizarre that any person from any company would attend an investor evening to deliver negative or neutral news, I have trouble seeing the point in that. Nothing to do with ramping share prices, Lupuzor and IMM as a company are a product, if you represent that product at a sales event you wouldn’t impress on the audience the negative points, you’re competitors can do that for you. I take it you’ve never been in sales as you don’t seem to understand the basics of selling your product. I believe the market sentiment since the placing has turned negative, it’s possible that IMM and TP believe that to be wrong and want an opportunity to put their side of the story, if investors then share that view and buy into the company that’s not ramping, it’s providing more information and possibly de-bunking some of the negative views on the placing which they may believe to be ill-conceived. Think you are confusing ‘ramping’ | harbourside | |
20/2/2018 20:17 | harbourside - it's got nothing to do with my "view" it's to do with probabilities...some You do realise that all your suggesting is that IMM and Turner Pope ramp the share price because they don't like the market's view of IMM? Re: would you not rather negotiate from a higher market cap then a smaller one, less ground to make up. No - because what you are suggesting is that "there is a bigger fool out there that will overpay"... | thebigshortfella |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions